High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2022 Jul 22

PMID 35864955

Authors

Lu Wang

Ji Zhang

Min Xia

Chang Liu

Xuyu Zu

Jing Zhong

Affiliations

Soon will be listed here.

Abstract

High mobility group A1 (HMGA1) is a nonhistone chromatin structural protein characterized by no transcriptional activity. It mainly plays a regulatory role by modifying the structure of DNA. A large number of studies have confirmed that HMGA1 regulates genes related to tumours in the reproductive system, digestive system, urinary system and haematopoietic system. HMGA1 is rare in adult cells and increases in highly proliferative cells such as embryos. After being stimulated by external factors, it will produce effects through the Wnt/β-catenin, PI3K/Akt, Hippo and MEK/ERK pathways. In addition, HMGA1 also affects the ageing, apoptosis, autophagy and chemotherapy resistance of cancer cells, which are linked to tumorigenesis. In this review, we summarize the mechanisms of HMGA1 in cancer progression and discuss the potential clinical application of targeted HMGA1 therapy, indicating that targeted HMGA1 is of great significance in the diagnosis and treatment of malignancy.

Citing Articles

Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer.

Zhang L, Zhao X, Gao X, Qin H, Chen F, Lin Z Cancer Cell Int. 2025; 25(1):80.

PMID: 40055693 PMC: 11887209. DOI: 10.1186/s12935-025-03713-1.

FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system.

Liu X, Zhang X, Zeng T, Chen Y, Ye L, Wang S J Transl Med. 2025; 23(1):268.

PMID: 40038751 PMC: 11877717. DOI: 10.1186/s12967-025-06304-w.

Deciphering key roles of B cells in prognostication and tailored therapeutic strategies for lung adenocarcinoma: a multi-omics and machine learning approach towards predictive, preventive, and personalized treatment strategies.

Zhang J, Hu D, Fang P, Qi M, Sun G EPMA J. 2025; 16(1):127-163.

PMID: 39991096 PMC: 11842682. DOI: 10.1007/s13167-024-00390-4.

Study on the expression of S100A4 and HMGA1 in endometrial carcinoma and their correlation with metastasis.

Pei X, Nie H, Liu Q, Xu C Am J Transl Res. 2025; 17(1):221-229.

PMID: 39959192 PMC: 11826162. DOI: 10.62347/QIBF6088.

The emerging roles of aberrant alternative splicing in glioma.

Ben Mrid R, El Guendouzi S, Mineo M, El Fatimy R Cell Death Discov. 2025; 11(1):50.

PMID: 39915450 PMC: 11802826. DOI: 10.1038/s41420-025-02323-0.

References

Liau S, Whang E . HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma. Clin Cancer Res. 2008; 14(5):1470-7. PMC: 2652398. DOI: 10.1158/1078-0432.CCR-07-1450. View

Radu M, Pradatu A, Duica F, Micu R, Cretoiu S, Suciu N . Ovarian Cancer: Biomarkers and Targeted Therapy. Biomedicines. 2021; 9(6). PMC: 8235073. DOI: 10.3390/biomedicines9060693. View

Zhang W, Lu Y, Shi H, Li X, Zhang Z, Deng X . LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis. Hum Cell. 2021; 34(5):1545-1557. DOI: 10.1007/s13577-021-00563-7. View

Esposito F, Boscia F, Gigantino V, Tornincasa M, Fusco A, Franco R . The high-mobility group A1-estrogen receptor β nuclear interaction is impaired in human testicular seminomas. J Cell Physiol. 2012; 227(12):3749-55. DOI: 10.1002/jcp.24087. View

Watanabe M, Ni S, Lindenberger A, Cho J, Tinch S, Kennedy M . Characterization of the Stoichiometry of HMGA1/DNA Complexes. Open Biochem J. 2013; 7:73-81. PMC: 3778555. DOI: 10.2174/1874091X01307010073. View

Hillion J, Smail S, Di Cello F, Belton A, Shah S, Huso T . The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology. 2012; 12(4):372-9. PMC: 3466102. DOI: 10.1016/j.pan.2012.05.005. View

Esposito F, De Martino M, DAngelo D, Mussnich P, Raverot G, Jaffrain-Rea M . HMGA1-pseudogene expression is induced in human pituitary tumors. Cell Cycle. 2015; 14(9):1471-5. PMC: 4615119. DOI: 10.1080/15384101.2015.1021520. View

De Martino M, Nicolau-Neto P, Pinto L, Traverse-Glehen A, Bachy E, Gigantino V . HMGA1 induces EZH2 overexpression in human B-cell lymphomas. Am J Cancer Res. 2021; 11(5):2174-2187. PMC: 8167683. View

Zhong J, Liu C, Chen Y, Zhang Q, Yang J, Kang X . The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion. J Transl Med. 2016; 14:80. PMC: 4804518. DOI: 10.1186/s12967-016-0824-x. View

10.

Brocher J, Vogel B, Hock R . HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation. BMC Cell Biol. 2010; 11:64. PMC: 2928187. DOI: 10.1186/1471-2121-11-64. View

11.

Lopez-Bertoni H, Lal B, Michelson N, Guerrero-Cazares H, Quinones-Hinojosa A, Li Y . Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene. 2016; 35(37):4903-13. PMC: 6151872. DOI: 10.1038/onc.2016.22. View

12.

Hillion J, Roy S, Heydarian M, Cope L, Xian L, Koo M . The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors. Gynecol Oncol. 2016; 141(3):580-587. PMC: 5770984. DOI: 10.1016/j.ygyno.2016.03.020. View

13.

Mansoori B, Najafi S, Mohammadi A, AsadollahSeraj H, Savadi P, Mansoori B . The synergy between miR-486-5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells. Biomed Pharmacother. 2021; 141:111925. DOI: 10.1016/j.biopha.2021.111925. View

14.

Gorbounov M, Carleton N, Asch-Kendrick R, Xian L, Rooper L, Chia L . High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer. Breast Cancer Res Treat. 2019; 179(1):25-35. PMC: 9301627. DOI: 10.1007/s10549-019-05419-1. View

15.

De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P . HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009; 69(5):1844-50. DOI: 10.1158/0008-5472.CAN-08-4133. View

16.

Chen X, Chen S . LINC00649 promotes bladder cancer malignant progression by regulating the miR‑15a‑5p/HMGA1 axis. Oncol Rep. 2021; 45(4). PMC: 7876990. DOI: 10.3892/or.2021.7959. View

17.

Liu H, Liu H, Li X . Use of Serine/Threonine Ligation for the Total Chemical Synthesis of HMGA1a Protein with Site-Specific Lysine Acetylations. Chempluschem. 2020; 84(7):779-785. DOI: 10.1002/cplu.201900130. View

18.

Meijer L, ostvold A, Walass S, Lund T, LALAND S . High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase. Eur J Biochem. 1991; 196(3):557-67. DOI: 10.1111/j.1432-1033.1991.tb15850.x. View

19.

Dong H, Sun S, Yan T, Liang C, Zhu J, Miao C . MicroRNA-195 inhibits proliferation and metastasis in renal cell carcinoma via regulating HMGA1. Am J Transl Res. 2020; 12(6):2781-2792. PMC: 7344069. View

20.

Wang C . MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells. Eur Rev Med Pharmacol Sci. 2019; 23(9):3771-3778. DOI: 10.26355/eurrev_201905_17803. View